These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22595318)

  • 21. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Abutaleb NS; Seleem MN
    Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report.
    Hitschfeld M; Tovar E; Gupta S; Bik EM; Palmer C; Hoaglin MC; Almonacid DE; Richman J; Apte ZS
    J Med Case Rep; 2019 Jan; 13(1):9. PubMed ID: 30642394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
    Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
    World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridioides difficile Biofilm.
    Vuotto C; Donelli G; Buckley A; Chilton C
    Adv Exp Med Biol; 2024; 1435():249-272. PubMed ID: 38175479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.
    Mitchell C; Keegan LT; Le TTT; Khader K; Beams A; Samore MH; Toth DJA
    PLoS One; 2024; 19(8):e0306622. PubMed ID: 39116083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Clostridium difficile Colonization.
    Crobach MJT; Vernon JJ; Loo VG; Kong LY; Péchiné S; Wilcox MH; Kuijper EJ
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540433
    [No Abstract]   [Full Text] [Related]  

  • 28. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlating Antibiotic-Induced Dysbiosis to
    Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
    ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of early-life events on the susceptibility to Clostridium difficile colonisation and infection in the offspring of the pig.
    Grześkowiak ŁM; Pieper R; Huynh HA; Cutting SM; Vahjen W; Zentek J
    Gut Microbes; 2019; 10(2):251-259. PubMed ID: 30252612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.
    Shin JH; High KP; Warren CA
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):916-22. PubMed ID: 26809495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of live biotherapeutics against
    Zhang Y; Saint Fleur A; Feng H
    Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337
    [No Abstract]   [Full Text] [Related]  

  • 34. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.
    Antharam VC; Li EC; Ishmael A; Sharma A; Mai V; Rand KH; Wang GP
    J Clin Microbiol; 2013 Sep; 51(9):2884-92. PubMed ID: 23804381
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Cheng JKJ; Unnikrishnan M
    Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
    [No Abstract]   [Full Text] [Related]  

  • 36. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
    Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
    PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
    Britton RA; Young VB
    Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
    Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
    Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial Activity of Tannic Acid
    Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J
    Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.